|
ZKSCAN4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.832300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.900200E-01 |
| Normal-vs-Stage2 |
3.867700E-02 |
| Normal-vs-Stage3 |
6.497400E-01 |
| Normal-vs-Stage4 |
3.374600E-01 |
| Stage1-vs-Stage2 |
1.242220E-01 |
| Stage1-vs-Stage3 |
9.937400E-01 |
| Stage1-vs-Stage4 |
1.538810E-01 |
| Stage2-vs-Stage3 |
2.629400E-01 |
| Stage2-vs-Stage4 |
2.809600E-02 |
| Stage3-vs-Stage4 |
2.941000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.063240E-01 |
| Normal-vs-AfricanAmerican |
2.197000E-01 |
| Normal-vs-Asian |
2.009600E-01 |
| Caucasian-vs-AfricanAmerican |
9.459800E-01 |
| Caucasian-vs-Asian |
6.972800E-01 |
| AfricanAmerican-vs-Asian |
7.473000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.218400E-01 |
| Normal-vs-Female |
1.887640E-02 |
| Male-vs-Female |
6.666000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.603600E-01 |
| Normal-vs-Extreme_Weight |
8.266600E-01 |
| Normal-vs-Obese |
2.557400E-01 |
| Normal-vs-Extreme_Obese |
5.871000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.917000E-01 |
| Normal_Weight-vs-Obese |
8.900800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.235800E-01 |
| Extreme_Weight-vs-Obese |
3.124000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.699800E-01 |
| Obese-vs-Extreme_Obese |
3.277400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.302400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.353960E-02 |
| Normal-vs-Age(61-80Yrs) |
3.861400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.197000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.190200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.073400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.482350E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.367900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.334300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.811580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.182000E-03 |
| Normal-VS-Type2 PRCC |
1.059760E-01 |
| Normal-VS-KIRP CIMP |
7.291800E-01 |
| Normal-VS-Unclassified PRCC |
1.217720E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.48499999999652E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.364000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.014000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.105600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.043000E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.135400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.425600E-01 |
| Normal-vs-N1 |
2.186600E-01 |
| Normal-vs-N2 |
3.711000E-01 |
| N0-vs-N1 |
1.844590E-01 |
| N0-vs-N2 |
5.284400E-01 |
| N1-vs-N2 |
3.418800E-01 |
|
|
